Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-26-015319·Anebulo Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
ANEBULO PHARMACEUTICALS INC
Common Stock · CUSIP: 034569103
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nantahala Capital Management, LLC
Shares: 3,547,398.00 · Class: 8.53%
- Wilmot B. Harkey
Shares: 3,547,398.00 · Class: 8.53%
- Daniel Mack
Shares: 3,547,398.00 · Class: 8.53%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-015319
- Form type
- SCHEDULE 13G/A
- Filer
- Anebulo Pharmaceuticals, Inc.
- CIK
- CIK 1815974
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership